Table 1: Baseline socio-demographic and clinical characteristics of study participants by art.

Variables

All subjects (2579)

ART (n = 2178)

Pre-ART (n = 401)

P-value

 

 

Number

Percentage

Number

Percentage

 

Sex

 

 

 

 

 

 

áMale

1148 (44.5)

995

45.7

153

38.2

0.006

Female

1431 (55.5)

1183

54.3

248

61.8

 

Age in Years (Mean ▒ sd)

32.5 ▒ 9.10

32.89 ▒ 9.01

 

30.78 ▒ 9.32

 

0.001

Marital Status

 

 

 

 

 

 

Married

1558 (60.4)

1286

59.0

272

67.8

0.001

Never Married

223 (8.6)

219

10.1

4

1.0

 

Divorced /Separated

591 (22.9)

467

21.4

124

30.9

 

Widowed

207 (8.0)

206

9.5

1

0.2

 

Literacy Status

 

 

 

 

 

 

Illiterate

414 (16.1)

396

18.2

18

4.5

0.001

Primary

1700 (65.9)

1346

61.8

354

88.3

 

Secondary and above

465 (18.0)

436

20.0

29

7.2

 

Baseline functional Status

 

 

 

 

 

 

Ambulatory

847 (32.8)

815

37.4

32

8.0

0.001

Bedridden

379 (14.7)

119

5.5

260

64.8

 

Working

1353 (52.5)

1244

57.1

109

27.2

 

Baseline Weight (Mean ▒ sd)

52.22 ▒ 9.13

52.22 ▒ 9.92

 

52.25 ▒ 1.48

 

0.949

WHO stage

 

 

 

 

 

 

Stage I

200 (7.8)

199

9.1

1

0.2

0.001

Stage II

415 (16.1)

334

15.3

81

20.2

 

Stage III

1749 (67.8)

1431

65.7

318

79.3

 

Stage IV

215 (8.3)

214

9.8

1

0.2

 

CD4 count at baseline (cells/ÁL) Mean ▒ sd

164.02 ▒ 117.84

163.99 ▒ 128.23

 

164.18 ▒ 5.27

 

0.976

Hemoglobin (g/dl) Mean ▒ sd

12.32 ▒ 1.84

12.32 ▒ 1.97

 

12.31 ▒ 0.69

 

0.875

CPT initiation

 

 

 

 

 

 

Before

230 (8.9)

230

10.6

0

0

0.001

With ART

2349 (91.1)

1948

89.4

401

100

 

INH initiation

 

 

 

 

 

 

NO

2128 (82.5)

1727

79.3

401

100

0.001

Before ART

65 (2.5)

65

3.0

0

0.0

 

After ART

386 (15.0)

386

17.7

0

0.0

 


ART: Antiretroviral Therapy; WHO: World Health Organization; CPT: Cotrimoxazole Prophylaxis Treatment; IPT: Isoniazid Preventive Therapy